Status:
COMPLETED
Medication Adherence in Hypertension Study
Lead Sponsor:
University of Missouri-Columbia
Collaborating Sponsors:
The John A. Hartford Foundation
Conditions:
Hypertension
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The purpose of this study is to test an intervention to help older adults do a better job of following blood pressure medication regimens prescribed by their health care providers.
Detailed Description
Hypertension is present in 26.7% of the U.S. adult population between ages 20 to 74 (National Center for Health Statistics, 2006). The prevalence increases with age. Sixty-seven percent of adults aged...
Eligibility Criteria
Inclusion
- Participants will be aged 60 years or greater at time of study entry.
- Participants must be able to read, write, and converse in English.
- Participants will have a diagnosis of hypertension (based on participant report).
- Participants will have an active prescription for at least one antihypertensive medication with no antihypertensive prescription changes for 30 days at the time of study entry.
- Participants must self-administer his or her own medications without prompts from any other person or device.
- Baseline medication adherence rate of \< 85%.
- Participants must be free of cognitive deficit as determined by a score of "normal" (0 - 2) on the Short Portable Mental Status Questionnaire (SPMSQ).
- Participants agree to complete all study contacts and measurements, including the use a special medication bottle with a Medication Event Monitoring System (MEMS) cap for the duration of the study.
- Able to open and close MEMS caps.
Exclusion
- Participant is in state of severe hypertension (BP of \>180/120 mmHg) at the time of study enrollment. Participants presenting with severely elevated blood pressure will be referred to their primary care provider.
- Participant resides in a residential facility where medications are administered by facility staff. Participants who reside in assisted living facilities but maintain control of their medications remain eligible.
- Participant has a terminal chronic illness with a life expectancy of six months or less.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00688350
Start Date
July 1 2008
End Date
June 1 2009
Last Update
October 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri
Columbia, Missouri, United States, 65211